Apyx Medical Corp Research And Development Expense

• Apyx Medical Corp showed a decrease of -33.6% in Research And Development Expense from 2024 to 2025.
• This data is from Apyx Medical Corp's annual report (Form 10-K), filed with the SEC on March 10, 2026.
• XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 17 years of available data (2009 to 2025), Apyx Medical Corp's Research And Development Expense has grown by 61.9%.
• Historical annual values: Fiscal year 2025: $3.37 million | Fiscal year 2024: $5.08 million | Fiscal year 2023: $5.44 million | Fiscal year 2022: $4.54 million | Fiscal year 2021: $4.32 million | Fiscal year 2020: $3.92 million | Fiscal year 2019: $3.73 million | Fiscal year 2018: $2.55 million | Fiscal year 2017: $1.94 million | Fiscal year 2016: $1.03 million | Fiscal year 2015: $2.16 million | Fiscal year 2014: $1.42 million | Fiscal year 2013: $1.26 million | Fiscal year 2012: $1.33 million | Fiscal year 2011: $1.20 million | Fiscal year 2010: $1.85 million | Fiscal year 2009: $2.08 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026